Achilles Therapeutics Plc Stock Technical Analysis
| ACHL Stock | USD 1.07 0.02 1.90% |
As of the 21st of November, Achilles Therapeutics shows the risk adjusted performance of 0.1158, and Mean Deviation of 2.04. Achilles Therapeutics PLC technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Achilles Therapeutics PLC downside variance, kurtosis, as well as the relationship between the treynor ratio and standard deviation to decide if Achilles Therapeutics PLC is priced correctly, providing market reflects its regular price of 1.07 per share. Given that Achilles Therapeutics is a hitting penny stock territory we recommend to closely look at its total risk alpha.
Achilles Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Achilles, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to AchillesAchilles |
Achilles Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 8.8 | Buy | 3 | Odds |
Most Achilles analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Achilles stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Achilles Therapeutics PLC, talking to its executives and customers, or listening to Achilles conference calls.
Achilles Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Achilles Therapeutics PLC Technical Analysis
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Achilles Therapeutics PLC volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Achilles Therapeutics PLC Trend Analysis
Use this graph to draw trend lines for Achilles Therapeutics PLC. You can use it to identify possible trend reversals for Achilles Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Achilles Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Achilles Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Achilles Therapeutics PLC applied against its price change over selected period. The best fit line has a slop of 0.01 , which means Achilles Therapeutics PLC will continue generating value for investors. It has 122 observation points and a regression sum of squares at 1.39, which is the sum of squared deviations for the predicted Achilles Therapeutics price change compared to its average price change.About Achilles Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Achilles Therapeutics PLC on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Achilles Therapeutics PLC based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Achilles Therapeutics PLC price pattern first instead of the macroeconomic environment surrounding Achilles Therapeutics PLC. By analyzing Achilles Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Achilles Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Achilles Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | PB Ratio | 0.5 | 0.18 | 0.25 | 0.24 | Capex To Depreciation | 2.32 | 2.04 | 0.23 | 0.22 |
Achilles Therapeutics November 21, 2024 Technical Indicators
Most technical analysis of Achilles help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Achilles from various momentum indicators to cycle indicators. When you analyze Achilles charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1158 | |||
| Market Risk Adjusted Performance | 0.4306 | |||
| Mean Deviation | 2.04 | |||
| Semi Deviation | 1.56 | |||
| Downside Deviation | 2.55 | |||
| Coefficient Of Variation | 701.19 | |||
| Standard Deviation | 4.55 | |||
| Variance | 20.66 | |||
| Information Ratio | 0.1216 | |||
| Jensen Alpha | 0.5086 | |||
| Total Risk Alpha | 0.1229 | |||
| Sortino Ratio | 0.2165 | |||
| Treynor Ratio | 0.4206 | |||
| Maximum Drawdown | 38.16 | |||
| Value At Risk | (2.88) | |||
| Potential Upside | 3.06 | |||
| Downside Variance | 6.52 | |||
| Semi Variance | 2.42 | |||
| Expected Short fall | (3.14) | |||
| Skewness | 5.48 | |||
| Kurtosis | 37.54 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Achilles Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Achilles Therapeutics. If investors know Achilles will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Achilles Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.66) | Return On Assets (0.27) | Return On Equity (0.44) |
The market value of Achilles Therapeutics PLC is measured differently than its book value, which is the value of Achilles that is recorded on the company's balance sheet. Investors also form their own opinion of Achilles Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Achilles Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Achilles Therapeutics' market value can be influenced by many factors that don't directly affect Achilles Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Achilles Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Achilles Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Achilles Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.